National Kidney Foundation Dialysis Outcomes Quality Initiative.Clinical practice guidelines for peritoneal dialysis adequacy.Am J Kidney Dis.1997; 30(Suppl 2): S67–136.
ChurchillD.N., TaylorD., KeshaviahP.R. for the Canada U.S.A. (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes.J Am Soc Nephrol.1996; 7: 198–207.
5.
TeehanB.P., SchleiferC.R., BrownJ.Urea kinetic modeling is an appropriate assessment of adequacy.Semin Dial.1992; 5: 189–92.
6.
FineA., CoxD.Modest reduction of serum albumin in continuous peritoneal dialysis is common and of no apparent clinical consequence.Am J Kidney Dis. 1992; 20: 50–4.
7.
StruijkD.G., KredietR.T., KoomenG.C.M., BoeschotenE.W., AriszL.The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival.Perit Dial Int.1994; 14: 121–6.
8.
CancariniG., CostantinoE., BrunoriG., ManiliL., CameriniC., spit tiC.Nutritional status in longterm CAPD patients. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Bulletin, 1992: 8: 84–7.
9.
Diaz-BuxoJ.A., ShultmanD.S.Characteristics of longterm peritoneal dialysis patients. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1997: 13: 104–8.
10.
AvramM.M., BonominiL.V., SreedharaR., MittmanN.Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years.Am J Kidney Dis.1996; 28: 910–17.
11.
GrzegorzewskaA., ChmurakA., Dobrowolska-ZachwiejaA.Nutrition of uremic patients in the course of CAPD treatment. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1996: 12: 293–7.
12.
MaiorcaR., CancariniG.C., CameriniC., BrunoriG., ManiliL., MovelliE.Is CAPD competitive with hemodialysis for long-term treatment of uremic patients?Nephrol Dial Transplant.1989; 4: 244–53.